Frank Slootman (NYSE: SNOW) exercises 99,900 options and sells shares under 10b5-1 plan
Rhea-AI Filing Summary
Snowflake Inc. director Frank Slootman exercised options and sold shares in a planned transaction. He exercised 99,900 shares of common stock at $8.88 per share and sold 99,900 shares in open-market trades around $250–$254 per share under a Rule 10b5-1 trading plan adopted on September 19, 2025. Following these trades, he holds 103,755 common shares directly, along with additional indirect holdings through several family trusts.
Positive
- None.
Negative
- None.
Insights
Slootman exercised 99,900 options and sold the resulting shares under a pre-set plan.
Frank Slootman exercised stock options for 99,900 Snowflake common shares at an exercise price of $8.88 per share and sold the same number of shares in multiple open-market transactions around $250–$254 per share.
The filing states these exercise-and-sell trades were executed under a Rule 10b5-1 trading plan adopted on September 19, 2025, indicating they were pre-arranged rather than opportunistic. After the sales, he holds 103,755 common shares directly, plus sizeable indirect positions via several family and grantor retained annuity trusts.
The option line shows 5,036,655 stock options remaining after this exercise, fully vested and expiring on May 28, 2029. This suggests the transaction is part of ongoing diversification and liquidity from a large equity-based position rather than a full-scale exit, though it is a notable sale relative to his direct share holdings.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 99,900 | $0.00 | -- |
| Exercise | Common Stock | 99,900 | $8.88 | $887K |
| Sale | Common Stock | 24,680 | $250.458 | $6.18M |
| Sale | Common Stock | 39,663 | $251.548 | $9.98M |
| Sale | Common Stock | 19,988 | $252.346 | $5.04M |
| Sale | Common Stock | 15,411 | $253.394 | $3.91M |
| Sale | Common Stock | 158 | $254.202 | $40K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- The exercise and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. Includes shares to be issued in connection with the vesting of one or more restricted stock units. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $250.000 to $250.990, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $251.000 to $251.995, inclusive. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $252.000 to $252.980, inclusive. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $253.010 to $253.970 inclusive. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $254.170 to $254.220, inclusive. The shares are held by the Slootman Grandchildren's Trust dated 7/28/2022 for which the Reporting Person is a trustee. The shares are held by the Slootman 2023 Children's Trust dated 9/25/2023 for which the Reporting Person is a trustee. The shares are held by the F. Slootman 2024 Grantor Retained Annuity Trust dated 12/3/2024 for which the Reporting Person is the trustee. The shares are held by the B. Slootman 2024 Grantor Retained Annuity Trust dated 12/3/2024 for which the Reporting Person's spouse is the trustee. The stock option is fully vested.